Mitochondrial adaptation during non-alcoholic fatty liver disease (NAFLD) include
remodeling of ketogenic flux and sustained tricarboxylic acid (TCA) cycle activity, which are …

Weight loss by ketogenic diet (KD) has gained popularity in management of nonalcoholic
fatty liver disease (NAFLD). KD rapidly reverses NAFLD and insulin resistance despite …

Together with the global rise in obesity and metabolic syndrome, the prevalence of
individuals who suffer from nonalcoholic fatty liver disease (NAFLD) has risen dramatically …

Diets rich in fats and carbohydrates aggravate non-alcoholic fatty liver disease (NAFLD), of
which mitochondrial dysfunction is a central feature. It is not clear whether a high …

Nonalcoholic fatty liver disease (NAFLD) is prevalent in patients with obesity or type 2
diabetes. Nonalcoholic steatohepatitis (NASH), encompassing steatosis with inflammation …

Elevated plasma branched-chain amino acids (BCAA) in the setting of insulin resistance
have been relevant in predicting type 2 diabetes mellitus (T2DM) onset, but their role in the …

Ketogenic diets induce hepatocyte fatty acid oxidation and ketone body production. To
further evaluate how ketogenic diets affect hepatocyte bioenergetic infrastructure, we …

Obesity‐associated insulin resistance plays a major role in the pathogenesis of non‐
alcoholic fatty liver disease (NAFLD). The accumulation of diacylglycerol (DAG), ceramides …

While several molecular targets are under consideration, mechanistic underpinnings of the
transition from uncomplicated nonalcoholic fatty liver disease (NAFLD) to nonalcoholic …

Objectives Metabolic-associated fatty liver disease (MAFLD) is the most common chronic
liver disease that can range from hepatic steatosis to non-alcoholic steatohepatitis (NASH) …